AI Tools for Research Coordinators

AI tools that help research coordinators manage study workflows, screen participants, track clinical trials, and prepare regulatory submissions.

Get started for free

Works in Chat, Cowork and Code

Nct numberSponsorPhase
NCT05312840Stanford MedicinePhase III
NCT05198034UCSFPhase II
NCT05421076AstraZenecaPhase III
NCT05288972Novo NordiskPhase II/III
23 recruiting trials found · 8 with CA sites

Clinical trial identification and screening

Search ClinicalTrials.gov for recruiting studies matching specific conditions, phases, and eligibility requirements. Quickly assess feasibility for your site or identify competing studies in your therapeutic area.

Find Phase II or III trials recruiting patients with relapsed/refractory multiple myeloma in the US. Show sponsor, phase, enrollment target, and primary endpoint.

Found 23 recruiting trials. Top results include a CAR-T cell therapy trial (NCT04649970, n=120), a bispecific antibody Phase III (NCT05024006, n=450), and an ADC study (NCT05140356, n=200). Primary endpoints range from ORR to PFS.

ToolRouter search_trials
Nct numberSponsorPhase
NCT04649970Bristol Myers SquibbPhase II
NCT05024006PfizerPhase III
NCT05140356AbbViePhase II
NCT05317429SanofiPhase III
23 recruiting trials found

Drug and medication safety review

Pull FDA-approved labeling, contraindications, and drug interaction data to support participant safety reviews, protocol development, and investigator brochure updates.

Pull the FDA label for pembrolizumab. I need the contraindications, immune-mediated adverse reactions, and dosing information for protocol review.

Retrieved FDA label for pembrolizumab (Keytruda). Contraindications: none listed. Key immune-mediated AEs: pneumonitis (3.4%), colitis (1.7%), hepatitis (0.7%), and endocrinopathies. Dosing: 200mg Q3W or 400mg Q6W IV.

ToolRouter get_drug_info
Contraindications
None listed in FDA prescribing information
Pneumonitis
3.4% incidence · Grade 3–4: 1.3% · monitor for new/worsening respiratory symptoms
Colitis
1.7% incidence · may require high-dose corticosteroids
Dosing
200 mg Q3W or 400 mg Q6W IV infusion

Scientific literature review

Search peer-reviewed literature to support protocol development, background sections, and investigator training materials. Surface the most relevant and recent evidence for any therapeutic area.

Find papers on the efficacy of SGLT2 inhibitors in heart failure with preserved ejection fraction (HFpEF) published since 2021.

Found 47 papers. Key results: EMPEROR-Preserved trial (Lancet, 2021) showed empagliflozin reduced CV death/HF hospitalization by 21%. DELIVER trial (NEJM, 2022) confirmed class effect with dapagliflozin. Meta-analysis of 6 RCTs confirms benefit across EF range.

ToolRouter search_papers
EMPEROR-Preserved (Lancet, 2021)
Empagliflozin reduced CV death/HF hospitalization by 21% in HFpEF
DELIVER Trial (NEJM, 2022)
Dapagliflozin confirmed class effect across EF range · NNT 22
Meta-analysis (2023)
6 RCTs confirm benefit · class effect for SGLT2i in HF across EF spectrum
Gap Identified
Limited mechanistic studies on HFpEF biomarkers and SGLT2i response

Study timeline and milestone tracking

Visualize study timelines, plot enrollment progress, and create milestone charts for sponsor and IRB reports. Keep stakeholders aligned with clear visual status updates.

Create a Gantt-style chart for our 18-month study. Milestones: IRB approval (Month 1), site initiation (Month 2), enrollment start (Month 3), last patient in (Month 12), database lock (Month 15), study report (Month 18).

Generated a horizontal timeline chart with 6 milestone markers across 18 months. Color-coded phases: startup (green), enrollment (blue), closeout (orange). Exportable as PNG for the sponsor progress report.

ToolRouter create_chart
Month 1
IRB Approval received
Month 2
Site initiation visit completed
Month 3
First Patient Enrolled
Month 12
Last Patient In (LPI)
Month 15
Database Lock
Month 18
Clinical Study Report

Sample and shipment tracking

Track biological sample shipments to central labs, ensure chain-of-custody compliance, and quickly identify delays before they affect data integrity or protocol timelines.

Track FedEx shipment 7745923812456 — this is a cryogenic sample package sent to the central lab. When does it arrive and has the temperature been maintained?

Shipment is in transit, currently at FedEx Indianapolis hub. Estimated delivery: tomorrow 10:30 AM. Last recorded temperature in transit log: -80°C. On schedule — no delays flagged.

ToolRouter track_package
Yesterday 14:32
Picked up at site · temperature -80°C verified
Today 03:15
In transit · FedEx Indianapolis Hub
Tomorrow 10:30
Estimated delivery · Central Lab · no delays flagged

Regulatory calendar and deadline tracking

Monitor FDA advisory committee meetings, guideline publication dates, and regulatory deadlines relevant to your study areas. Never miss a submission window or comment period.

What FDA advisory committee meetings are scheduled in the next 90 days? I need to track any oncology or cardiology panels.

Found 4 upcoming FDA AdCom meetings: (1) ODAC for prostate cancer NDA (April 14), (2) CRDAC for HFrEF device (May 2), (3) ODAC for NSCLC combo therapy (May 19), (4) CRDAC for atrial fibrillation treatment (June 7).

ToolRouter search_news
Apr 14
ODAC · Prostate cancer NDA · Pfizer
May 2
CRDAC · HFrEF device review
May 19
ODAC · NSCLC combination therapy
Jun 7
CRDAC · Atrial fibrillation treatment NDA

Ready-to-use prompts

Find recruiting trials

Search for Phase II or III clinical trials recruiting adults with treatment-resistant depression in the United States. Include NCT number, sponsor, enrollment target, and contact information.

Drug safety review

Pull the FDA label for apixaban. Summarize contraindications, warnings, drug interactions, and dosing adjustments for renal impairment.

Literature search

Find peer-reviewed papers published in the last 2 years on CAR-T cell therapy for B-cell lymphoma. Summarize response rates and key toxicity findings from clinical trials.

Study timeline chart

Create a bar chart showing monthly enrollment targets vs. actual enrollment for a 12-month study. Target: 10 patients/month. Actual: 8, 9, 11, 7, 12, 10, 13, 11, 9, 14, 12, 11.

Track sample shipment

Track DHL shipment 1234567890 containing biological specimens. Confirm current location, estimated delivery time, and any delays.

Protocol background research

Research the mechanism of action, clinical evidence, and safety profile of GLP-1 receptor agonists for use in a protocol background section. Cite key pivotal trials.

Competing study landscape

Find all active clinical trials for Alzheimer's disease prevention using amyloid-targeting therapies. Show phase, sponsor, enrollment status, and primary completion date.

Tools to power your best work

165+ tools.
One conversation.

Everything research coordinators need from AI, connected to the assistant you already use. No extra apps, no switching tabs.

New study feasibility assessment

Evaluate whether your site can support a new study by reviewing the competitive landscape, patient population availability, and protocol requirements.

1
Clinical Trials icon
Clinical Trials
Identify competing trials recruiting in your therapeutic area and geography
2
Drug Information icon
Drug Information
Review investigational drug labeling and known safety signals
3
Academic Research icon
Academic Research
Pull literature on the patient population and standard of care

Ongoing study status reporting

Compile monthly or quarterly progress reports for sponsors with enrollment data, milestone status, and any protocol deviations.

1
Generate Chart icon
Generate Chart
Build enrollment progress charts comparing actual vs. target
2
Package Tracker icon
Package Tracker
Confirm all sample shipments received and logged
3
Clinical Trials icon
Clinical Trials
Verify study record is up to date on ClinicalTrials.gov

Protocol development support

Gather scientific evidence to support a new or amended protocol, from background literature through safety review.

1
Academic Research icon
Academic Research
Search primary literature for disease background and current SOC
2
Drug Information icon
Drug Information
Pull drug labeling for investigational and comparator agents
3
Generate Chart icon
Generate Chart
Visualize key efficacy data from published studies for the rationale section

Frequently Asked Questions

How current is the clinical trials data?

Clinical Trials pulls live data directly from ClinicalTrials.gov, which is updated daily by study sponsors and investigators. Trial status, enrollment numbers, and contact information reflect the most recently submitted data.

Can I use drug information data for clinical decisions?

Drug Information provides FDA-approved labeling data for reference and research purposes. For clinical decision-making, always verify with the current prescribing information and consult your institutional pharmacist. This tool is designed to support protocol review and training, not clinical practice.

Does academic research cover all journals?

Academic Research aggregates from PubMed/MEDLINE, arXiv, Semantic Scholar, Crossref, and open-access repositories — covering the vast majority of peer-reviewed biomedical and scientific literature. Some journals with restricted access may return abstracts only.

Can I track temperature-controlled shipments?

Package Tracker retrieves standard carrier tracking data including location and estimated delivery. Actual temperature monitoring requires the carrier's cold-chain logging service — the tracking data alone cannot confirm temperature compliance. Always use the carrier-provided cold-chain documentation for regulatory purposes.

Can these tools help with IRB submissions?

Yes. Academic Research helps compile literature for the background section, Drug Information provides labeling data for safety narratives, and Generate Chart creates enrollment projection figures. The tools support document preparation — submission itself requires your institutional system.

More AI tools by profession

Give your AI superpowers.

Get started for free

Works in Chat, Cowork and Code